MedTrace Logo

Unloading Induced Effects on Local Glucose Uptake Into m. Soleus

NCT02698878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2016-03-08

No results posted yet for this study

Summary

The present study aimed to investigate whether a daily intake of lupin protein and a neuromuscular electrical stimulation training twice a day can improve local glucose uptake into m. soleus during a 60 day unloading phase with a special unloading device, the HEPHAISTOS orthosis (HEP).

Conditions

  • Local Glucose Uptake
  • Glucose Metabolism Disorders

Interventions

DIETARY_SUPPLEMENT

lupin protein

19g of lupin crunchy every day for the whole duration of the intervention phase (60 days)

OTHER

Neuromuscular electrical stimulation

Individual neuromuscular electrical stimulation training had to be performed twice a day (morning and evening) over the whole duration of the intervention phase (60 days). Subjects were asked to continuously increase the intensity until a maximum intensity of 100mA per training.

DEVICE

HEPHAISTOS unloading orthotic device

Orthotic device which unloads the muscles of the lower leg. Subjects had to wear the device for the whole duration of the intervention phase (60 days).

Sponsors & Collaborators

  • DLR German Aerospace Center

    lead OTHER

Principal Investigators

  • Jörn Rittweger, Prof. Dr. · DLR German Aerospace Center

  • Kathrin Schopen, M.Sc. · DLR German Aerospace Center

  • Petra Frings-Meuthen, Dr. · DLR German Aerospace Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-08-31
Completion
2014-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02698878 on ClinicalTrials.gov